Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-59-nucleotidase (CD73) and the A2B adenosine receptor

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4367-4374

  Hart, Melanie L ^a   Grenz, Almut ^b   Gorzolla, Iris C ^a   Schittenhelm, Jens ^c   Dalton, Julee H ^b   Eltzschig, Holger K ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2B RECEPTOR; ECTO 5' NUCLEOTIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

A2BAR GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD73 GENE; CONTROLLED STUDY; GENE; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE ISCHEMIA; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN TARGETING; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 79954994463     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903617     Document Type: Article

References (45)

1. Tendler, D. A. 2003. Acute intestinal ischemia and infarction. Semin. Gastrointest. Dis. 14: 66-76. (Pubitemid 36850430)
2. Mallick, I. H., W. Yang, M. C. Winslet, and A. M. Seifalian. 2004. Ischemiareperfusion injury of the intestine and protective strategies against injury. Dig. Dis. Sci. 49: 1359-1377. (Pubitemid 39273608)
3. Cummins, E. P., E. Berra, K. M. Comerford, A. Ginouves, K. T. Fitzgerald, F. Seeballuck, C. Godson, J. E. Nielsen, P. Moynagh, J. Pouyssegur, and C. T. Taylor. 2006. Prolyl hydroxylase-1 negatively regulates IkappaB kinasebeta, giving insight into hypoxia-induced NFkappaB activity. Proc. Natl. Acad. Sci. USA 103: 18154-18159. (Pubitemid 44871628)
4. Taylor, C. T. 2008. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J. Physiol. 586: 4055-4059.
5. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920. (Pubitemid 34024743)
6. Sitkovsky, M., and D. Lukashev. 2005. Regulation of immune cells by localtissue oxygen tension: HIF1 alpha and adenosine receptors. Nat. Rev. Immunol. 5: 712-721. (Pubitemid 43086172)
7. Sitkovsky, M. V., D. Lukashev, S. Apasov, H. Kojima, M. Koshiba, C. Caldwell, A. Ohta, and M. Thiel. 2004. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22: 657-682. (Pubitemid 38680437)
8. Thiel, M., A. Chouker, A. Ohta, E. Jackson, C. Caldwell, P. Smith, D. Lukashev, I. Bittmann, and M. V. Sitkovsky. 2005. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3: e174.
9. Eckle, T., D. Köhler, R. Lehmann, K. C. El Kasmi, and H. K. Eltzschig. 2008. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118: 166-175.
10. Eltzschig, H. K., P. Abdulla, E. Hoffman, K. E. Hamilton, D. Daniels, C. Schönfeld, M. Löffler, G. Reyes, M. Duszenko, J. Karhausen, et al. 2005. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 202: 1493-1505. (Pubitemid 41746596)
11. Morote-Garcia, J. C., P. Rosenberger, J. Kuhlicke, and H. K. Eltzschig. 2008. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111: 5571-5580.
12. Thompson, L. F., H. K. Eltzschig, J. C. Ibla, C. J. Van De Wiele, R. Resta, J. C. Morote-Garcia, and S. P. Colgan. 2004. Crucial role for ecto-59-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200: 1395-1405. (Pubitemid 39657287)
13. Eltzschig, H. K., J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796. (Pubitemid 37087777)
14. Synnestvedt, K., G. T. Furuta, K. M. Comerford, N. Louis, J. Karhausen, H. K. Eltzschig, K. R. Hansen, L. F. Thompson, and S. P. Colgan. 2002. Ecto-59- nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110: 993-1002.
15. Kong, T., K. A. Westerman, M. Faigle, H. K. Eltzschig, and S. P. Colgan. 2006. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20: 2242-2250. (Pubitemid 44953854)
16. Hart, M. L., B. Jacobi, J. Schittenhelm, M. Henn, and H. K. Eltzschig. 2009. Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J. Immunol. 182: 3965-3968.
17. Hart, M. L., C. Much, I. C. Gorzolla, J. Schittenhelm, D. Kloor, G. L. Stahl, and H. K. Eltzschig. 2008. Extracellular adenosine production by ecto-59-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 135: 1739-1750.
18. Louis, N. A., A. M. Robinson, C. F. MacManus, J. Karhausen, M. Scully, and S. P. Colgan. 2008. Control of IFN-alphaA by CD73: implications for mucosal inflammation. J. Immunol. 180: 4246-4255.
19. Frick, J. S., C. F. MacManus, M. Scully, L. E. Glover, H. K. Eltzschig, and S. P. Colgan. 2009. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J. Immunol. 182: 4957-4964.
20. Hart, M. L., M. Henn, D. Köhler, D. Kloor, M. Mittelbronn, I. C. Gorzolla, G. L. Stahl, and H. K. Eltzschig. 2008. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J. 22: 2784-2797.
21. Grenz, A., H. Osswald, T. Eckle, D. Yang, H. Zhang, Z. V. Tran, K. Klingel, K. Ravid, and H. K. Eltzschig. 2008. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 5: e137.
22. Eckle, T., A. Grenz, S. Laucher, and H. K. Eltzschig. 2008. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J. Clin. Invest. 118: 3301-3315.
23. Eckle, T., T. Krahn, A. Grenz, D. Köhler, M. Mittelbronn, C. Ledent, M. A. Jacobson, H. Osswald, L. F. Thompson, K. Unertl, and H. K. Eltzschig. 2007. Cardioprotection by ecto-59-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590. (Pubitemid 46648643)
24. Karhausen, J., G. T. Furuta, J. E. Tomaszewski, R. S. Johnson, S. P. Colgan, and V. H. Haase. 2004. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114: 1098-1106. (Pubitemid 39578699)
25. Morote-Garcia, J. C., P. Rosenberger, N. M. Nivillac, I. R. Coe, and H. K. Eltzschig. 2009. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology 136: 607-618.
26. Cummins, E. P., F. Seeballuck, S. J. Keely, N. E. Mangan, J. J. Callanan, P. G. Fallon, and C. T. Taylor. 2008. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134: 156-165.
27. Taylor, C. T., and S. P. Colgan. 2007. Hypoxia and gastrointestinal disease. J. Mol. Med. 85: 1295-1300. (Pubitemid 50004090)
28. Lang, S. A., C. Moser, A. Gaumann, D. Klein, G. Glockzin, F. C. Popp, M. H. Dahlke, P. Piso, H. J. Schlitt, E. K. Geissler, and O. Stoeltzing. 2007. Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth. Clin. Cancer Res. 13: 6459-6468. (Pubitemid 350075036)
29. Haeberle, H. A., C. Dü rrstein, P. Rosenberger, Y. M. Hosakote, J. Kuhlicke, V. A. Kempf, R. P. Garofalo, and H. K. Eltzschig. 2008. Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS ONE 3: e3352.
30. Kuhlicke, J., J. S. Frick, J. C. Morote-Garcia, P. Rosenberger, and H. K. Eltzschig. 2007. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS ONE 2: e1364.
31. Faigle, M., J. Seessle, S. Zug, K. C. El Kasmi, and H. K. Eltzschig. 2008. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS ONE 3: e2801.
32. Chiu, C. J. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch. Surg. 101: 478-483.
33. Eltzschig, H. K. 2009. Adenosine: an old drug newly discovered. Anesthesiology 111: 904-915.
34. Aragonés, J., P. Fraisl, M. Baes, and P. Carmeliet. 2009. Oxygen sensors at the crossroad of metabolism. Cell Metab. 9: 11-22.
35. Rosenberger, P., J. M. Schwab, V. Mirakaj, E. Masekowsky, A. Mager, J. C. Morote-Garcia, K. Unertl, and H. K. Eltzschig. 2009. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10: 195-202.
36. Fraisl, P., J. Aragonés, and P. Carmeliet. 2009. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat. Rev. Drug Discov. 8: 139-152.
37. Werth, N., C. Beerlage, C. Rosenberger, A. S. Yazdi, M. Edelmann, A. Amr, W. Bernhardt, C. von Eiff, K. Becker, A. Schäfer, et al. 2010. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS ONE 5: e11576.
38. Löffler, M., J. C. Morote-Garcia, S. A. Eltzschig, I. R. Coe, and H. K. Eltzschig. 2007. Physiological roles of vascular nucleoside transporters. Arterioscler. Thromb. Vasc. Biol. 27: 1004-1013. (Pubitemid 46641985)
39. Eltzschig, H. K., L. F. Thompson, J. Karhausen, R. J. Cotta, J. C. Ibla, S. C. Robson, and S. P. Colgan. 2004. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992. (Pubitemid 39620148)
40. Ahmad, A., S. Ahmad, L. Glover, S. M. Miller, J. M. Shannon, X. Guo, W. A. Franklin, J. P. Bridges, J. B. Schaack, S. P. Colgan, and C. W. White. 2009. Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells. Proc. Natl. Acad. Sci. USA 106: 10684-10689.
41. Ryan, H. E., J. Lo, and R. S. Johnson. 1998. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17: 3005-3015. (Pubitemid 28254373)
42. Carmeliet, P., Y. Dor, J. M. Herbert, D. Fukumura, K. Brusselmans, M. Dewerchin, M. Neeman, F. Bono, R. Abramovitch, P. Maxwell, et al. 1998. Role of HIF- 1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. [Published erratum appears in 1998 Nature 395: 525.] Nature 394: 485-490. (Pubitemid 28373960)
43. Robinson, A., S. Keely, J. Karhausen, M. E. Gerich, G. T. Furuta, and S. P. Colgan. 2008. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134: 145-155. (Pubitemid 350309309)
44. Hart, M. L., D. Köhler, T. Eckle, D. Kloor, G. L. Stahl, and H. K. Eltzschig. 2008. Direct treatment of mouse or human blood with soluble 59-nucleotidase inhibits platelet aggregation. Arterioscler. Thromb. Vasc. Biol. 28: 1477-1483.
45. Koeppen, M., T. Eckle, and H. K. Eltzschig. 2009. Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo. PLoS ONE 4: e6784.